HealthStream EVP exercises 18,000 options, sells shares

Q: How many HSTM shares did Michael Manning Collier sell?

Michael Manning Collier sold 18,000 shares at a weighted-average price of $29.8535 and another 3,300 shares at a weighted-average price of $30.5972 on November 5, 2026.

Q: What were the trade-price ranges for Michael Manning Collier’s HSTM sales?

The 18,000-share sale had a reported range of $29.41 to $30.36, and the 3,300-share sale had a reported range of $30.23 to $31.01.

Both sales were reported at weighted-average prices, and the 18,000-share option exercise and sale used a broker-assisted cashless exercise.

Available on EDGAR 11/06/2026 - 04:31 PM EST Accepted by SEC EDGAR 11/06/2026 - 04:30 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

HealthStream (HSTM) Executive Vice President Michael Manning Collier exercised options for 18,000 common shares on November 5, 2026, at an exercise price of $20.34 per share, then sold 18,000 shares at a weighted-average price of $29.8535. He also sold 3,300 shares at a weighted-average price of $30.5972. The 18,000-share exercise and sale were effected through a broker-assisted cashless exercise. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 4 txns

Insider Collier Michael Manning

Role Executive Vice President

Sold 21,300 shs ($638K)

Approx. gross sale proceeds $638K

Approx. exercise cost $366K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (right to buy) ^F4	18,000	$0.00	$0.00
Sale	Common Stock ^F1	3,300	$30.5972	$101K
Exercise	Common Stock	18,000	$20.34	$366K
Sale	Common Stock ^{F2, F3}	18,000	$29.8535	$537K

Holdings After Transaction: Employee Stock Option (right to buy) — 0 contracts (Direct); Common Stock — 59,260 shares (Direct)

Footnotes (4)

F1. This transaction was executed in multiple trades at prices ranging from $30.23 to $31.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F2. The exercise and sale were effected through a broker-assisted cashless exercise.
F3. This transaction was executed in multiple trades at prices ranging from $29.41 to $30.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F4. The options vested according to the following schedule: 15% vested on December 9, 2021, 20% vested on December 9, 2022, 30% vested on December 9, 2023, and the remaining 35% vested on December 9, 2024.

Key Figures

Options exercised: 18,000 options Exercise price: $20.34 per share Shares sold through cashless exercise: 18,000 shares +4 more

7 metrics

Options exercised 18,000 options November 5, 2026

Exercise price $20.34 per share For the 18,000 shares acquired on November 5, 2026

Shares sold through cashless exercise 18,000 shares November 5, 2026

Weighted-average sale price $29.8535 per share 18,000-share sale; reported trade range $29.41 to $30.36

Additional shares sold 3,300 shares November 5, 2026

Weighted-average sale price $30.5972 per share 3,300-share sale; reported trade range $30.23 to $31.01

Options following transaction 0 options Following the November 5, 2026 transaction

Key Terms

Employee Stock Option (right to buy), broker-assisted cashless exercise, weighted average sale price, exercise price

4 terms

Employee Stock Option (right to buy) technical

"Employee Stock Option (right to buy)"

broker-assisted cashless exercise financial

"effected through a broker-assisted cashless exercise"

weighted average sale price financial

"reflects the weighted average sale price"

exercise price financial

"at an exercise price of $20.34 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HSTM shares did Michael Manning Collier sell?

Michael Manning Collier sold 18,000 shares at a weighted-average price of $29.8535 and another 3,300 shares at a weighted-average price of $30.5972 on November 5, 2026.

What were the trade-price ranges for Michael Manning Collier’s HSTM sales?

The 18,000-share sale had a reported range of $29.41 to $30.36, and the 3,300-share sale had a reported range of $30.23 to $31.01.

When did Michael Manning Collier’s HSTM options vest?

15% vested on December 9, 2021; 20% on December 9, 2022; 30% on December 9, 2023; and the remaining 35% on December 9, 2024.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Collier Michael Manning

(Last)

(First)

(Middle)

500 11TH AVENUE NORTH

SUITE 850

(Street)

NASHVILLE

TENNESSEE

37203

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HEALTHSTREAM INC [ HSTM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Executive Vice President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/05/2026		S		3,300	D	$30.5972⁽¹⁾	59,260	D
Common Stock	11/05/2026		M		18,000	A	$20.34	77,260	D
Common Stock	11/05/2026		S⁽²⁾		18,000	D	$29.8535⁽³⁾	59,260	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (right to buy)	$20.34	11/05/2026		M			18,000	⁽⁴⁾	12/09/2030	Common Stock	18,000	$0	0	D

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $30.23 to $31.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

2. The exercise and sale were effected through a broker-assisted cashless exercise.

3. This transaction was executed in multiple trades at prices ranging from $29.41 to $30.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

4. The options vested according to the following schedule: 15% vested on December 9, 2021, 20% vested on December 9, 2022, 30% vested on December 9, 2023, and the remaining 35% vested on December 9, 2024.

	/s/ Michael M. Collier	11/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR